The Hepatic Coma Syndromes and Lactulose

The Hepatic Coma Syndromes and Lactulose

In his prefatory note Dr. Rosenberg tells the unfortunate story of this book's publication. It had been quietly planned in early 1977 and was intended to be presented to George Rosen in the spring of 1978, marking his retirement. This effort was unexpectedly transformed into a memorial volume when Dr. Rosen died suddenly in the summer of 1977. George Rosen was one of the preeminent medical hist...

Hepatic coma: the electroencephalographic pattern.

Recent advances in our knowledge of the neurophysiologic mechanisms underlying sleep and experimental states of coma (1) suggest the need for a neurophysiologic approach to the many complex clinical syndromes associated with disturbance of consciousness. The coma syndrome associated with hepatic disease and usually known as hepatic coma was chosen for investigation since it presents a good exam...

The mechanism of hepatic coma.

Hepatic Encephalopathy; to Compare the Efficacy of Lactulose Alone and Lactulose with Rifaxamin in Patients of Hepatic Encephalopathy

.. Background: Hepatic encephalopathy is one of the fatal complications of liver cirrhosis in clinical setting. A number of drugs with varied response have been tried up till now. Objectives: To compare the efficacy of lactulsoe alone and in combination with rifaxamin in cases with hepatic encephalopathy. Study Design: Randomized control trail. Setting: Sheikh Zayed Hospital (SZH) Rahim Yar Kha...

Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.

INTRODUCTION Hepatic encephalopathy is challenging complication of liver dysfunction. Therapeutic treatment options for hepatic encephalopathy are currently limited and have appreciable risks and benefits associated with their use. Rifaximin is a novel anti microbiological agent with wide spectrum of activity that has shown promise as an alternative option for hepatic encephalopathy. AIMS AND...